查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1534973

弹性成像市场：现况分析与预测（2024-2032）

Elastography Imaging Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 138 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于企业併购的增加，弹性成像市场预计将以10%左右的速度稳定成长。例如，2024年7月，美国GE医疗同意收购Intelligent Ultrasound Group PLC的临床人工智慧（AI）软体业务。 GE HealthCare 计划将这些解决方案纳入其整个超音波产品组合，透过改善工作流程并提高易用性的技术来增强其功能，造福临床医生和患者。其他因素，如慢性病的增加、对微创诊断程序的日益偏好以及公司之间的策略联盟，将在预测期内推动市场成长。除此之外，弹性成像成像的可承受性和可用性的提高也在稳步推动这个市场。

市场依程序分为超音波弹性成像、磁振造影弹性成像等。超音波弹性成像领域因其非侵入性、成本效益以及评估各种医疗状况的多功能性而在2023年占据市场主导地位。在该领域，基于超音波的技术用于量化组织硬度，这对于评估肝臟纤维化、乳房组织和肌肉骨骼疾病非常重要。新的发展包括超音波弹性成像解析度的提高和即时分析，这些改进促进了临床诊断的高精度和广泛应用。该细分市场的扩张伴随着对诊断医疗保健、慢性病的流行以及对多样化且负担得起的影像解决方案的需求的日益关注。因此，超音波弹性成像可应用于一般诊断和特殊诊断，在现代医学中具有很高的需求。

依模式划分，市场分为携带式和固定式。预计携带式设备将在预测期内显着成长。携带式弹性成像在市场上的需求量很大，因为它用途广泛、易于使用，并且可以根据患者的要求应用于不同的临床领域。手持式弹性成像与携带式超音波系统整合的优点在于，可以在需要时提供所需的成像和评估，使其适合农村和偏远地区、急诊室和其他护理点环境。这些设备的开发能够提供出色的影像解析度和硬度测量，同时保持携带和易于使用，这要归功于技术的可用性。由于需要行动医疗服务的人数不断增加、对快速检测结果的需求以及医疗服务范围的扩大，携带式细分市场预计将成长。这是由于在灵活的新技术的帮助下，人们不断转向提高疾病诊断和治疗的可及性和有效性。因此，预计携带式细分市场在预测期内将显着成长。

在市场区隔方面，产品依用途分为心臟病、放射、泌尿、血管、妇产科等。2023年的市场将由心臟病学领域主导。弹性成像市场在心臟病学领域经历显着成长，该领域为非侵入性评估和治疗心血管疾病提供了创新的解决方案。弹性成像方法逐渐被引进心血管实践中，以评估心肌硬度和纤维化参数，这对于心臟衰竭、肥厚性心肌病变和心肌梗塞等病理状况的诊断和监测非常重要。随着高解析度、即时弹性成像技术的发展和可用性的提高，心臟病的早期诊断已成为可能。该领域的成长是由心血管疾病的日益普及、开发更有效的技术来诊断这些疾病的需求以及从心血管护理到个人化方法的转变所推动的。弹性成像技术利用测量组织机械特性（例如弹性）的技术，这项发展支持弹性成像技术在增强对患者的心臟护理方面的使用的增加。因此，心臟病学领域在2023年的应用中占据了重要的市场占有率。

为了更了解弹性成像的市场导入，市场根据北美（美国、加拿大、北美其他地区）、欧洲（德国、法国、英国、西班牙、义大利、欧洲其他地区）、亚太地区（中国、日本、印度、亚太其他地区）和其他地区的全球影响力进行分析。由于新产品的推出、公司透过併购扩张、对非侵入性诊断的日益偏好、临床研究的增加以及慢性病发病率的上升，预计北美在预测期内将出现显着成长。弹性成像成像的可承受性和可用性的提高也推动了该地区的市场成长。因此，在这些地区中，预计北美在预测期内将出现最大的成长。

市场上的主要公司包括 CANON MEDICAL SYSTEMS CORPORATION、Esaote SPA、FUJIFILM Corporation、GE HealthCare、Hologic, Inc.、Koninklijke Philips N.V.、Mindray DS USA, Inc.、Resoundant, Inc.、SAMSUNGHEALTHCARE.COM、Siemens Healthcare Private Limited等。

目录

第一章 市场介绍

  • 市场定义
  • 主要目的
  • 利害关係人
  • 限制

第二章 研究方法或前提

  • 调查过程
  • 调查方法
  • 受访者简介

第3章 执行摘要

  • 行业概况
  • 依细分市场进行预测
    • 市场成长的力量
  • 区域展望

第4章 市场动态

  • 促进因素
  • 机会
  • 抑制因素
  • 趋势
  • PESTEL 分析
  • 需求方分析
  • 供给面分析
    • 併购
    • 投资场景
    • 产业洞察：主要新创公司及其独特策略

第五章 价格分析

  • 区域价格分析
  • 影响价格的因素

第6章 2022-2032年全球弹性成像市场营收

第七章 技术市场分析

  • 超音波弹性成像
  • 磁振造影弹性成像
  • 其他

第8章 依模式划分的市场分析

  • 携带式
  • 已修復

第9章 依应用程式进行市场分析

  • 心臟病
  • 辐射
  • 泌尿系统
  • 船隻
  • 妇产科
  • 其他

第10章 依地区划分的市场分析

  • 北美
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区

第11章 价值链分析

  • 边际分析
  • 进入市场的公司名单

第十二章 竞争态势

  • 竞争对手仪表板
  • 竞争市场定位分析
  • 波特五力分析

第十三章 公司简介

  • CANON MEDICAL SYSTEMS CORPORATION
  • Esaote SPA
  • FUJIFILM Corporation
  • GE HealthCare
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Mindray DS USA, Inc.
  • Resoundant, Inc.
  • SAMSUNGHEALTHCARE.COM
  • Siemens Healthcare Private Limited

第14章 首字母缩写与先决条件

第15章 附录

简介目录
Product Code: UMHE212972

Elastography imaging is a detailed diagnostic modality that is used in measuring tissue's stiffness and elasticity for the purpose of diagnosing as well as managing different disease conditions based on the structural features of tissues. As a mechanical wave-based imaging method, elastography facilitates diagnosing tissue conditions without biopsy, especially for fibrosis, tumors, and musculoskeletal diseases. This technology entails techniques such as transient elastography and shear wave elastography, which are expanding on integration with real-time imaging, and artificial intelligence for improved diagnosing proficiency. Technological advancement in the trend of identifying diseases through non-invasive procedures and adopting patient-specific approaches, including disease diagnosis, has remained instrumental in the construction of elastography imaging across different practices.

The Elastography Imaging Market is expected to grow at a steady rate of around 10% owing to the rising company mergers and acquisitions. For instance, in July 2024, U.S.-based GE HealthCare agreed to acquire Intelligent Ultrasound Group PLC's clinical artificial intelligence (AI) software business. GE Healthcare plans to incorporate these solutions across the ultrasound portfolio, strengthening its capabilities with technology that helps improve workflows and enhance ease of use for the benefit of clinicians and patients. Other factors, including the rising chronic disorders, increasing preference for minimally invasive diagnostic procedures, and strategic partnerships between companies, drive the market's growth during the forecast period. Apart from this, improving the affordability and accessibility of elastography imaging are also driving this market steadily.

Based on the technique, the market is segmented into ultrasound elastography, magnetic resonance elastography, and others. The ultrasound elastography segment dominated the market in the year 2023 driven by its non-invasive nature, cost-effectiveness, and versatility in assessing a wide range of medical conditions. In this segment, the technology used is based on ultrasound for quantification of tissue hardness which is vital in the assessment of liver fibrosis, breast tissues, and disorders of the musculoskeletal system. New developments include improvement in resolution and real-time analysis of ultrasound elastography as these improvements promote high accuracy and broad utilization in clinical diagnosis. The expansion of the segment is supplemented by growing healthcare concerns on diagnostics, the prevalence of chronic diseases, along with the need for diverse affordable imaging solutions. Therefore, ultrasound elastography can be applied for ordinary and specific diagnostic tasks being in high demand in modern medicine.

Based on modality, the market is bifurcated into portable and stationary. The portable segment is expected to grow significantly in the forecast period. The portable type of elastography imaging is experiencing great demand in the market because of its versatility, easy access, and applicability across various areas of clinical practice and patient requirements. Hand-held elastography integrated with portable ultrasound devices has the advantage of point-of-need imaging and assessment which may suit rural and remote areas, emergency departments, and some other point-of-care settings. The development of these devices to provide good image resolution and stiffness measurements while remaining portable and easy to use is due to the availability of technology. The portable segment is expected to grow due to the growing number of people requiring health care services on the go, the need for fast testing results, and the expansion of the scope of medical services. It is attributed to an ongoing shift towards improving the access and effectiveness of diagnosing and treating diseases with the aid of new and flexible technologies. Thus, the portable segment is expected to grow significantly in the forecast period among the modality.

Based on the application, the market is segmented into cardiology, radiology, urology, vascular, obstetrics, and others. The cardiology segment dominated the market in the year 2023. In the elastography imaging market, the cardiology segment has seen significant growth as it offers an innovative solution for evaluating and treating cardiovascular diseases non-invasively. Elastography methods are gradually implemented in sites of cardiological practice in order to assess the parameters of myocardial hardness and fibrosis which are essential for diagnostics as well as the monitoring of pathologies, for example, heart failure, hypertrophic cardiomyopathy, and myocardial infarction. Development and progress in the availability of high-resolution and real-time elastography are enabling better diagnostics of cardiac conditions at an early stage. Segment growth is driven by the increasing incidence of cardiovascular diseases, the need to develop more effective technologies for diagnosing these diseases, and the transition from cardiologic practice to individualized approaches. Elastography leverages technology to determine mechanical properties of the tissue, such as elasticity, and this development underlines the increasing use of elastography in enhancing patients' cardiac care delivery. Thus, the cardiology segment held a significant market share in 2023 among the applications.

For a better understanding of the market adoption of elastography imaging, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to grow at a significant rate in the forecast period due to new product launches, rising company expansions with mergers & acquisitions, rising preference for non-invasive diagnostic procedures, an increasing number of clinical studies, and a rise in chronic disorders. For instance, U.S.-based Emory University initiated a clinical trial to utilize Shear Wave Elastography (SWE) to study the viscoelastic properties of tendons to understand the functional differences between normal/asymptomatic and symptomatic tendon states, which is expected to be completed by 2025. Other factors, such as the improvement in affordability and accessibility of elastography imaging, have pushed the region's market growth. Thus, amongst areas, North America is expected to grow at a significant rate in the forecast period.

Some of the major players operating in the market include CANON MEDICAL SYSTEMS CORPORATION; Esaote SPA; FUJIFILM Corporation; GE HealthCare; Hologic, Inc.; Koninklijke Philips N.V.; Mindray DS USA, Inc.; Resoundant, Inc.; SAMSUNGHEALTHCARE.COM; Siemens Healthcare Private Limited.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Elastography Imaging Market
  • 2.2. Research Methodology of the Elastography Imaging Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Investment Scenario
    • 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

  • 5.1. Regional Pricing Analysis
  • 5.2. Price Influencing Factors

6.GLOBAL ELASTOGRAPHY IMAGING MARKET REVENUE (USD BN), 2022-2032F

7.MARKET INSIGHTS BY TECHNIQUE

  • 7.1. Ultrasound Elastography
  • 7.2. Magnetic Resonance Elastography
  • 7.3. Others

8.MARKET INSIGHTS BY MODALITY

  • 8.1. Portable
  • 8.2. Stationary

9.MARKET INSIGHTS BY APPLICATION

  • 9.1. Cardiology
  • 9.2. Radiology
  • 9.3. Urology
  • 9.4. Vascular
  • 9.5. Obstetrics/Gynecology
  • 9.6. Others

10.MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11.VALUE CHAIN ANALYSIS

  • 11.1. Marginal Analysis
  • 11.2. List of Market Participants

12.COMPETITIVE LANDSCAPE

  • 12.1. Competition Dashboard
  • 12.2. Competitor Market Positioning Analysis
  • 12.3. Porter Five Forces Analysis

13.COMPANY PROFILES

  • 13.1. CANON MEDICAL SYSTEMS CORPORATION
    • 13.1.1. Company Overview
    • 13.1.2. Key Financials
    • 13.1.3. SWOT Analysis
    • 13.1.4. Product Portfolio
    • 13.1.5. Recent Developments
  • 13.2. Esaote SPA
  • 13.3. FUJIFILM Corporation
  • 13.4. GE HealthCare
  • 13.5. Hologic, Inc.
  • 13.6. Koninklijke Philips N.V.
  • 13.7. Mindray DS USA, Inc.
  • 13.8. Resoundant, Inc.
  • 13.9. SAMSUNGHEALTHCARE.COM
  • 13.10. Siemens Healthcare Private Limited

14.ACRONYMS & ASSUMPTION

15.ANNEXURE